HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eiji Nanba Selected Research

GM1 Gangliosidosis (Gangliosidosis GM1)

8/2020An autopsy case of GM1 gangliosidosis type II in a patient who survived a long duration with artificial respiratory support.
5/2014Structural basis of pharmacological chaperoning for human β-galactosidase.
3/2013A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.
8/2011Lysosomal accumulation of Trk protein in brain of GM₁ -gangliosidosis mouse and its restoration by chemical chaperone.
11/2009Intracerebral cell transplantation therapy for murine GM1 gangliosidosis.
9/2006Fibroblast screening for chaperone therapy in beta-galactosidosis.
12/2003Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eiji Nanba Research Topics

Disease

12Gaucher Disease (Gaucher's Disease)
01/2020 - 08/2004
9Autistic Disorder (Autism)
02/2009 - 01/2004
8Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2019 - 12/2003
7GM1 Gangliosidosis (Gangliosidosis GM1)
08/2020 - 12/2003
5Tuberous Sclerosis (Bourneville's Disease)
02/2021 - 06/2002
5Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
10/2017 - 09/2002
5Mucopolysaccharidosis IV (Morquio Syndrome)
05/2014 - 12/2003
4Neurologic Manifestations (Neurological Manifestations)
11/2017 - 09/2007
4Glycogen Storage Disease Type II (Pompe's Disease)
01/2013 - 10/2003
4Neoplasms (Cancer)
09/2011 - 06/2002
3Epilepsy (Aura)
02/2021 - 06/2002
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 08/2011
3Neuraminidase deficiency with beta-galactosidase deficiency
01/2019 - 10/2008
3Mucolipidoses (Sialidosis)
05/2016 - 12/2009
3Neurodevelopmental Disorders
01/2015 - 01/2007
2Intellectual Disability (Idiocy)
02/2021 - 01/2016
2Hyperinsulinism (Hyperinsulinemia)
02/2021 - 12/2017
2Fragile X Tremor Ataxia Syndrome
01/2021 - 12/2014
2Metachromatic Leukodystrophy (Sulfatide Lipidosis)
01/2021 - 01/2008
2Fetal Growth Retardation (Intrauterine Growth Retardation)
12/2017 - 08/2005
2Seizures (Absence Seizure)
09/2017 - 01/2017
2Fabry Disease (Fabry's Disease)
09/2015 - 07/2014
2Hyperthyroidism
01/2015 - 05/2014
2Graves Disease (Basedow Disease)
01/2015 - 05/2014
2Sphingolipidoses (Sphingolipidosis)
04/2013 - 08/2004
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
11/2011 - 12/2008
2Hamartoma
09/2007 - 04/2004
2Neuroblastoma
02/2007 - 11/2005
2Ischemia
06/2005 - 03/2004
2Reperfusion Injury
06/2005 - 08/2004
1Tay-Sachs Disease
12/2022
1Spasm (Spasms)
05/2021
1Malformations of Cortical Development
02/2021
1Astrocytoma (Pilocytic Astrocytoma)
02/2021
1Angiofibroma
02/2021
1Infantile Spasms (West Syndrome)
02/2021
1Gliosis
02/2021
1Malnutrition (Nutritional Deficiencies)
02/2021
1Premature Birth (Birth, Premature)
02/2021
1Ataxia (Dyssynergia)
01/2021
1Tremor (Tremors)
01/2021
1Adenocarcinoma
01/2021
1Pain (Aches)
01/2020
1Anemia
01/2020
1Lymphoma (Lymphomas)
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Mannosidase Deficiency Diseases (Mannosidosis)
01/2019
1Splenomegaly
08/2018
1Narcolepsy
08/2018
1Disease Progression
08/2018

Drug/Important Bio-Agent (IBA)

10AcidsIBA
01/2021 - 10/2003
9EnzymesIBA
12/2022 - 10/2011
9Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2004
9Glucosylceramidase (Glucocerebrosidase)IBA
07/2018 - 11/2010
8GalactosidasesIBA
08/2020 - 08/2011
5trans-sodium crocetinate (crocetin)IBA
02/2021 - 06/2002
5GlucosidasesIBA
04/2014 - 11/2010
3Messenger RNA (mRNA)IBA
02/2021 - 06/2004
3Cathepsin AIBA
01/2019 - 10/2008
3Neuraminidase (Sialidase)IBA
01/2019 - 10/2008
3Pharmaceutical PreparationsIBA
09/2017 - 04/2013
3Ambroxol (Mucosolvan)IBA
03/2016 - 04/2013
3LipidsIBA
02/2014 - 06/2004
3beta-Galactosidase (Lactaid)IBA
10/2008 - 09/2006
3N-octyl-beta-valienamineIBA
09/2006 - 12/2003
2Insulin (Novolin)FDA Link
02/2021 - 09/2006
2Cerebroside-Sulfatase (Arylsulfatase A)IBA
01/2021 - 01/2008
2HydrolasesIBA
08/2020 - 10/2011
2CyclodextrinsIBA
01/2017 - 04/2014
2UDP- N- acetylglucosamine- lysosomal- enzyme- N- acetylglucosaminephosphotransferaseIBA
05/2016 - 12/2009
2mutalipocin IIIBA
05/2016 - 10/2011
2Nonsense Codon (Nonsense Mutation)IBA
12/2015 - 05/2002
2Phosphotransferases (Kinase)IBA
03/2015 - 10/2011
2GlycosidesIBA
01/2015 - 08/2012
2Long-Acting Thyroid Stimulator (LATS)IBA
01/2015 - 05/2014
2migalastatIBA
07/2014 - 03/2013
2alpha-Glucosidases (Acid Maltase)IBA
11/2012 - 10/2003
2Carrier Proteins (Binding Protein)IBA
11/2011 - 12/2008
2Cardiac MyosinsIBA
11/2011 - 12/2008
2Glutamic Acid (Glutamate)FDA Link
09/2007 - 05/2007
2Tuberous Sclerosis Complex 1 ProteinIBA
09/2007 - 05/2007
2Biological ProductsIBA
05/2006 - 11/2005
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
05/2006 - 10/2002
1Hexosaminidase A (Hex A)IBA
12/2022
1Hexosaminidases (Hexosaminidase)IBA
12/2022
1Protons (Proton)IBA
05/2021
1Adrenocorticotropic Hormone (ACTH)FDA Link
05/2021
1protoporphyrin IXIBA
01/2021
1Sulfoglycosphingolipids (Sulfatides)IBA
01/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020
1alpha-Mannosidase (LAMAN)IBA
01/2019
1MannosidasesIBA
01/2019
1Modafinil (Provigil)FDA Link
08/2018
1Filipin (Filipin III)IBA
08/2018
1miglustat (Zavesca)FDA Link
11/2017

Therapy/Procedure

12Therapeutics
05/2021 - 12/2003
2Enzyme Replacement Therapy
01/2020 - 11/2012
2Drug Therapy (Chemotherapy)
09/2011 - 03/2002
1Cholecystectomy
01/2021
1Splenectomy
01/2020